CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

FGFR1 rearrangement (myeloid/lymphoid neoplasms)

Gene: FGFR1 · Type: fusion

Indications: Myeloid/lymphoid neoplasms

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
PemigatinibMyeloid/lymphoid neoplasmsINDICATED
FDA Label
Label